Dynamin and Rab5a-dependent Trafficking and Signaling of the Neurokinin 1 Receptor*

Fabien SchmidlinDagger , Olivier DéryDagger , Kathryn O. DeFeaDagger , Lee Slice§, Simona Patierno§, Catia Sternini§, Eileen F. GradyDagger , and Nigel W. BunnettDagger ||

Departments of Dagger  Surgery and § Physiology, University of California San Francisco, San Francisco, California 94143-0660 and  CURE Digestive Diseases Research Center, West Los Angeles Veterans Affairs Medical Center and Departments of Medicine and Neurobiology, UCLA Medical School, Los Angeles, California 90073-1792

Received for publication, February 22, 2001


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Understanding the molecular mechanisms of agonist-induced trafficking of G-protein-coupled receptors is important because of the essential role of trafficking in signal transduction. We examined the role of the GTPases dynamin 1 and Rab5a in substance P (SP)-induced trafficking and signaling of the neurokinin 1 receptor (NK1R), an important mediator of pain, depression, and inflammation, by studying transfected cells and enteric neurons that naturally express the NK1R. In unstimulated cells, the NK1R colocalized with dynamin at the plasma membrane, and Rab5a was detected in endosomes. SP induced translocation of the receptor into endosomes containing Rab5a immediately beneath the plasma membrane and then in a perinuclear location. Expression of the dominant negative mutants dynamin 1 K44E and Rab5aS34N inhibited endocytosis of SP by 45 and 32%, respectively. Dynamin K44E caused membrane retention of the NK1R, whereas Rab5aS34N also impeded the translocation of the receptor from superficially located to perinuclear endosomes. Both dynamin K44E and Rab5aS34N strongly inhibited resensitization of SP-induced Ca2+ mobilization by 60 and 85%, respectively, but had no effect on NK1R desensitization. Dynamin K44E but not Rab5aS34N markedly reduced SP-induced phosphorylation of extracellular signal regulated kinases 1 and 2. Thus, dynamin mediates the formation of endosomes containing the NK1R, and Rab5a mediates both endosomal formation and their translocation from a superficial to a perinuclear location. Dynamin and Rab5a-dependent trafficking is essential for NK1R resensitization but is not necessary for desensitization of signaling. Dynamin-dependent but not Rab5a-dependent trafficking is required for coupling of the NK1R to the mitogen-activated protein kinase cascade. These processes may regulate the nociceptive, depressive, and proinflammatory effects of SP.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Agonist-induced trafficking of G-protein-coupled receptors (GPCRs)1 and associated proteins plays an essential role in signal transduction (reviewed in Refs. 1 and 2). Within seconds of stimulation, G-protein receptor kinases and second messenger kinases translocate from the cytoplasm to the plasma membrane, where they phosphorylate receptors (3-5). beta -Arrestins are multifunctional proteins that interact with G-protein receptor kinase-phosphorylated receptors at the plasma membrane. This interaction disrupts association of GPCRs with heterotrimeric G-proteins and thereby mediates uncoupling and desensitization (6-8). beta -Arrestins also serve as adaptors for clathrin-mediated endocytosis of certain GPCRs, which contributes to desensitization by depleting the cell surface of receptors (9-13). In addition, beta -arrestins are scaffolds that recruit components of the MAP kinase cascade into endosomes, which is necessary for mitogenic signaling (14-16). Once internalized, GPCRs recycle to the cell surface, which mediates resensitization (17-20), or are degraded in lysosomes, which down-regulates receptors (21-24). However, despite the importance of receptor trafficking for signal transduction, the molecular mechanisms are not fully understood. Most information derives from studies of very few receptors and is not necessarily applicable to all GPCRs. Furthermore, most observations are made using transfected cells expressing very high levels of GPCRs, which need not represent cells that naturally express these receptors at physiological levels.

We investigated the mechanisms and function of substance P (SP)-induced endocytosis of the neurokinin-1 receptor (NK1R) in transfected cell lines and enteric neurons that naturally express this receptor. An understanding of the mechanisms that regulate this system is important, because SP and the NK1R mediate pain, depression, inflammation, smooth muscle contraction, and exocrine secretion (25, 26). SP induces endocytosis and recycling of the NK1R in neurons and endothelial cells that participate in pain and inflammation (11, 18, 27-31). However, the molecular mechanisms of this trafficking and its importance in signal transduction are unknown.

We examined the role of the GTPases dynamin and ras-related GTPase 5a (Rab5a) in SP-induced endocytosis of the NK1R and determined the importance of this trafficking for desensitization, resensitization, and mitogenic signaling. The cytosolic GTPase dynamin mediates the first steps of endosome formation at sites of clathrin-coated pits and caveoli (32, 33). Dynamin is required for constitutive endocytosis of the transferrin receptor as well as agonist-induced endocytosis of some GPCRs (12, 13, 34-38). However, some GPCRs internalize by dynamin-independent processes (12, 37, 39, 40). Rab5a mediates later steps of formation of endosomes containing the transferrin receptor and is required for endosomal translocation to a perinuclear region (41-43). However, very little is known about the role of Rab5a in trafficking of GPCRs other than recent observations that Rab5a participates in the formation of endosomes containing the dopamine D2 and beta 2-adrenergic (beta 2-AR) receptors (38, 44) and contributes to down-regulation of the kappa -opioid receptor (24). Nothing is known about the role of dynamin and Rab5a in trafficking of the NK1R, and the relative roles of dynamin and Rab5a in desensitization, resensitization and mitogenic signaling of GPCRs are unknown.

Our aims were to (a) determine the role of dynamin and Rab5a in SP-induced endocytosis and intracellular trafficking of the NK1R by expressing dominant negative mutants of these GTPases; (b) compare the importance of dynamin and Rab5a-dependent trafficking for desensitization and resensitization of signal transduction; (c) define the role of this trafficking for mitogenic signaling; and (d) establish whether dynamin and Rab5a could contribute to trafficking of the NK1R in neurons that naturally express this receptor.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Reagents and Antibodies-- Enhanced green fluorescent protein (EGFP) expression vector pEGFP-C1, expression vector pIRES2-EGFP, and JM109 bacteria were from CLONTECH (Palo Alto, CA). Restriction enzymes, T4 ligase, and Lipofectin were from Life Technologies, Inc. or New England Biolabs, Inc. (Beverly, MA). Exp Tag DNA polymerase was from Stratagene (La Jolla, CA). A QiaEx extraction kit was from Qiagen (Hilden, Germany). G418 was from Gemini Bio-Products, Inc. (Calabashes, CA). Kanamycin and protease inhibitor mixture were from Calbiochem. Glutathione-agarose was from Amersham Pharmacia Biotech. The ECL detection kit was from Amersham Pharmacia Biotech. The Alexa594 protein labeling kit was from Molecular Probes, Inc. (Eugene, OR). SP or the NK1R-selective agonist [Sar9,MetO211]SP was labeled with Alexa594 as described (45). 125I-SP (2,000 µCi/mol) was from Amersham Pharmacia Biotech. Antibodies to Rab5a, dynamin, extracellular signal-regulated kinases 1 and 2 (ERK1/2), and phosphorylated ERK1/2 (pERK1/2) were from Transduction Laboratories (Santa Cruz, CA). The sources of other reagents and of antibodies to FLAG and 12CA5 epitopes, NK1R, EGFP, and fluorescence- or enzyme-tagged secondary antibodies have been described (11, 22, 23, 46-48).

Generation of Rab5a-GFP and HA-Dynamin Constructs-- Canine Rab5a and the GTPase-defective binding mutant Rab5aS34N were fused to EGFP at the N terminus by PCR using the forward primer 5'-GGCCGGAATTCCATGGCTAATCGAGGAGCAACA-3' (EcoRI site underlined followed by translation initiation site) and the reverse primer 5'-GGCCGGGGATCCTTAGTTACTACAACACTGACTCCT-3' (BamHI restriction site underlined followed by stop codon). Rab5a cDNA was used as template to amplify an 800-bp fragment that was separated on an agarose gel and purified using a QiaEx extraction kit. The PCR fragment and the vector pEGFP-C1 were digested with EcoRI and BamHI and ligated with the T4 ligase overnight at 16 °C. Chemically competent JM109 bacteria were transformed using the heat shock method and selected on LB medium containing 30 µg/ml of Kanamycin. Correct sequences were verified. Rab5a tagged with EGFP is fully functional (42). Generation and use of pcDNA3.1-HA-dynamin I and HA-dynamin I K44E (N-terminal HA.11 epitopes), a dominant negative mutant that lacks GTPase activity, have been described (34). HA-dynamin-pIRES-EGFP constructs were generated by enzymatic digestion of pcDNA3.1-HA-dynamin with XhoI and XbaI and insertion of DNA into pIRES2-EGFP. The pIRES-EGFP construct enabled convenient identification of transfected cells using EGFP while avoiding attachment of EGFP to dynamin, which impairs its function (49).

Generation of Transfected Cells-- Kirsten murine sarcoma virus-transformed rat kidney epithelial cells (KNRK) were from the American Type Tissue Culture Collection (Manassas, VA). Generation of KNRK cells stably expressing rat NK1R with N-terminal FLAG epitope (KNRK-FLAGNK1R cells), which does not affect receptor function, has been described (50). To generate a cell line stably expressing FLAGNK1R plus Rab5a-GFP or Rab5aS34N-GFP, KNRK-FLAGNK1R cells were transfected with cDNA encoding Rab5a-GFP or Rab5aS34N-GFP (11). Clones were screened by fluorescence microscopy and flow cytometry to detect NK1R and Rab5a. Cells were also transiently transfected with Rab5a and dynamin, since stable expression of dominant negative dynamin caused cell death, and to enable simultaneous comparison of transfected and untransfected cells by microscopy. KNRK-FLAGNK1R cells were transiently transfected by overnight incubation with 5 µg/ml cDNA encoding Rab5a-GFP, Rab5aS34N-GFP, HA-dynamin, or HA-dynamin K44E by lipofection. The medium was replaced, and cells were studied 24 h later. To transiently express HA-dynamin-pIRES-EGFP or HA-dynamin K44E-pIRES-EGFP, KNRK-FLAGNK1R cells were transfected by electroporation (Bio-Rad) and plated for 18 h, and positive transfected cells were sorted and plated 24 h before experiments. Cell lines are designated KNRK-NK1R+Rab5a, KNRK-NK1R+Rab5aS34N, KNRK-NK1R+DYN, or KNRK-NK1R+DYNK44E (where DYN represents dynamin). Cells were prepared for experiments as described (11, 27) and were usually incubated with 5 mM sodium butyrate for 18 h before use to boost expression of transfected genes. As a control, KNRK-FLAGNK1R cells were transfected with vectors without the Rab5a or dynamin inserts. Expression of empty vectors or EGFP alone did not affect signaling or trafficking of the NK1R (see Ref. 11; data not shown) or related receptors (23).

Flow Cytometry-- Flow cytometry was used to monitor expression of NK1R, Rab5a, and dynamin and to enrich populations of transfected cells (11, 23). To detect the NK1R, cells were resuspended in 1 ml of Iscove's medium containing 1 mg/ml bovine serum albumin, with 10 µg/ml M2 antibody to the extracellular FLAG for 1 h at 4 °C, washed, and incubated with 2 µg/ml phycoerythrin-conjugated goat anti-mouse IgG for 1 h at 4 °C. Expression of other constructs was determined using EGFP. Cells were analyzed using a Facscan flow cytometer (Becton Dickinson Co., Franklin Lakes, NJ). Fluorophores were excited at 488 nm, and emission was collected at 530/30 nm for EGFP and 575/25 nm for phycoerythrin.

Western Blotting-- Western blotting was used to confirm expression of Rab5a and dynamin (11, 23). Cells (107) were pelleted and lysed in 1 ml of Laemmli buffer. Lysates were fractionated by SDS-PAGE (4-15%), and proteins were transferred to nitrocellulose. Membranes were incubated with 5% nonfat milk in 100 mM PBS, pH 7.4, overnight and with antibodies to EGFP (9708; 1:1,000-1:20,000, 8 h, 4 °C), Rab5a, or dynamin (1:1,000, 2 h, room temperature). Membranes were washed and incubated with goat anti-rabbit IgG conjugated to horseradish peroxidase (1:8,000, 1 h, room temperature). Proteins were detected on film using an ECL detection kit. Controls included preabsorption of the diluted primary antibody with the EGFP fusion protein (1-2 µg/ml) for 1 h at 37 °C and use of nontransfected KNRK cells.

Endocytosis of 125I-SP-- The rate of NK1R endocytosis was quantified with 125I-SP (27). Cells were incubated in Hanks' balanced salt solution containing 50 pM 125I-SP, 0.1% bovine serum albumin for 60 min at 4 °C. They were washed and incubated at 37 °C for 0-10 min. Cells were washed with ice-cold PBS and incubated in 250 µl of ice-cold 0.2 M acetic acid containing 500 mM NaCl (pH 2.5) on ice for 5 min to separate acid-labile (cell surface) from acid-resistant (internalized) label. Nonspecific binding was measured in the presence of 1 µM SP and was subtracted to give specific binding. Observations were in triplicate in n > 3 experiments. KNRK cells expressing empty vector without NK1R insert do not bind or take up 125I-SP (50).

Measurement of [Ca2+]i-- [Ca2+]i was measured in populations of transfected cells using Fura-2/AM (11, 27). Fluorescence was measured at 340- and 380-nm excitation and 510-nm emission, and the results were expressed as the ratio of the fluorescence at the two excitation wavelengths, which is proportional to the [Ca2+]i. Cells were exposed once to SP to generate concentration-response curves. For desensitization experiments, cells were exposed to SP or vehicle (control) for 2 min, washed, and exposed again to SP 5 min after the first exposure. To examine resensitization, cells were incubated with SP or vehicle (control) for 10 min, washed, and challenged with SP 0-180 min after washing. All observations were in n > 3 experiments. KNRK cells expressing empty vector without the NK1R insert do not mobilize [Ca2+]i in response to SP (50).

MAP Kinase Assays-- SP-induced phosphorylation of ERK1/2 was determined by Western blotting (15, 16). Similar results were obtained in kinase assays using myelin basic protein as a substrate (data not shown). Cells were maintained serum-free medium overnight and incubated with 10 nM SP for 0-30 min at 37 °C. Cells were lysed in boiling 20 mM Tris-HCl, pH 8, 10 mM EDTA, 0.3% SDS, 67 mM DTT. Lysates (20 µg of protein) were analyzed by 12% SDS-PAGE and transferred to polyvinylidene difluoride membranes. Membranes were incubated with pERK1/2 (pERK) antibody (1:1000, overnight, 4 °C), followed by goat anti-mouse IgG conjugated to horseradish peroxidase (1:30,000, 1 h, room temperature). Proteins were visualized by ECL. Blots were stripped and reprobed with antibody to total ERK1/2 to ensure that equal levels of ERK1/2 were present at each time point. The intensities of the combined ERK1 and ERK2 bands for phosphorylated and total proteins were determined by histogram analysis (mean density × number pixels) (15, 16). Intensities of the pERK bands were normalized to total ERKs to correct for any differences in loading. Results are expressed as the -fold increase in pERK1/2 relative to unstimulated cells. All observations were in n = 4 experiments.

NK1R Trafficking in Cell Lines-- Cells were incubated with 10-100 nM Alexa594-SP for 60 min at 4 °C (for equilibrium binding), washed at 4 °C, and either fixed immediately or incubated in SP-free medium at 37 °C for 2.5-10 min (for trafficking to proceed) (11, 18). Cells were fixed with 4% paraformaldehyde in 100 mM PBS, pH 7.4, for 20 min at 4 °C. NK1R was localized using Alexa-SP or by immunofluorescence using the M2 FLAG antibody (10 µg/ml, 18 h, 4 °C) or an antibody to the C terminus of the rat NK1R (1:1,000, 18 h, 4 °C). Rab5a was localized using EGFP, and dynamin was localized by immunofluorescence using the HA antibody (4 µg/ml, 18 h, 4 °C) (11, 18). Fluorescent SP does not bind to untransfected KNRK cells (45).

NK1R Trafficking in Enteric Neurons-- Organotypic cultures were prepared from the rat ileum (Harlan Sprague-Dawley, male, 200-250 g, Harlan Laboratories, San Diego, CA) as previously described for guinea pigs (48). Excised segments of distal were opened along the mesentery, pinned flat, and incubated in Krebs solution containing 100 nM SP for 1 h at 4 °C. Specimens were either immediately fixed or incubated in SP-free medium for 20 min at 37 °C (48). Specimens were fixed in 4% paraformaldehyde for 2 h and washed, and whole mounts of the longitudinal muscle with attached myenteric plexus were prepared. Tissues were processed for sequential immunofluorescence using a C-terminally directed rabbit antibody to NK1R (1:500, 48 h, 4 °C) and a monoclonal dynamin antibody (1:50, 48 h, 4 °C), followed by secondary antibodies labeled with contrasting fluorophores. The sequential double labeling procedure was chosen because preliminary experiments showed that mixing the NK1R and dynamin antibodies did not give clear staining of individual antigens. Myenteric neurons from the small intestine of newborn male guinea pigs (Duncan-Hartley; Simonsen, Gilroy, CA) were dispersed and cultured exactly as described (30, 31). Neurons were studied at days 7-14 of culture. Neurons were incubated with 100 nM Alexa594-SP or Alexa594-[Sar9,MetO211]SP for 120 min at 4 °C, washed at 4 °C, and either fixed immediately or incubated in SP-free medium at 37 °C for 5-30 min (30, 31). Neurons were fixed with 4% paraformaldehyde for 20 min at 4 °C. NK1R was detected using Alexa-SP, and Rab5a was localized by immunofluorescence with a polyclonal antibody (1:50, 2 h, 4 °C) (30, 31).

Microscopy-- Specimens were observed using a Zeiss Axiovert 100 microscope (Carl Zeiss Inc., Thornwood, NY) with an MRC 1000 confocal microscope (Bio-Rad) or a Zeiss 410 confocal microscope (30, 48). Images were collected at 0.5-µm intervals using a × 100 PlanApo 1.4 NA objective and a zoom of 1-2 and were processed using Adobe Photoshop (Adobe Systems, Mountain View, CA).

Statistical Analysis-- Results are expressed as means ± S.E. Differences between values were analyzed by one-way analysis of variance and the Student-Newman-Keul's test, with p < 0.05 considered to be significant.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Characterization of Cell Lines Expressing NK1R, Dynamin, and Rab5a-- We selected KNRK cells, since they regulate NK1R signaling and trafficking similarly to neurons that naturally express the NK1R (11, 18, 27, 30, 31). We transiently transfected KNRK-FLAGNK1R cells with HA-dynamin-pIRES-GFP or HA-dynamin K44E-pIRES-GFP and sorted EGFP-expressing cells (Fig. 1A). Western blotting identified an intensely immunoreactive band corresponding to dynamin in cells expressing dynamin and dynamin K44E, which was far more intense than that observed in nontransfected cells (Fig. 1B). NK1R was detected at the cell surface in close proximity to dynamin and dynamin K44E, which were also detected in the cytosol (Fig. 1C). We stably expressed the FLAGNK1R in a hygromycin-resistant vector and Rab5a-GFP or Rab5aS34N-GFP in a neomycin-resistant vector. We used KNRK-NK1R+Rab5a clone 10 and KNRK-NK1R+Rab5aS34N clone 3 in all experiments. Flow cytometry revealed a single population of cells highly expressing NK1R plus Rab5a or Rab5aS34N (Fig. 2A). Western blotting with a Rab5a antibody detected endogenous Rab5a (~30 kDa) in all cell lines and also detected Rab5a-GFP (~55 kDa) corresponding to Rab5a (~30 kDa) plus EGFP (~27 kDa) in transfected cells (Fig. 2B, left panel). The EGFP antibody detected only a band at ~55 kDa cells expressing Rab5a-GFP or Rab5aS34N-GFP (Fig. 2B, right panel). Immunoreactive NK1R was localized to the plasma membrane, Rab5a was detected in superficial and perinuclear vesicles, and Rab5aS34N was mostly present in the cytosol (Fig. 2C). To verify that cells expressed functional NK1R, we measured SP-induced Ca2+ mobilization. In all cells, SP stimulated a prompt increase in [Ca2+]i (not shown, but see Fig. 8) with EC50 values similar to that measured in cells expressing NK1R alone (~0.6 nM).


View larger version (84K):
[in this window]
[in a new window]
 
Fig. 1.   Characterization of cells expressing FLAGNK1R plus HA-dynamin or HA-dynamin K44E. KNRK-FLAGNK1R cells were transiently transfected with HA-dynamin or HA-dynamin K44E in the pIRES-GFP vector. A, analysis by flow cytometry confirmed the high efficiency of transfection. B, Western blotting of enriched cells using a dynamin antibody revealed high expression of dynamin in transfected compared with untransfected cells. C, confocal microscopy showed colocalization of NK1R (detected with FLAG antibody) with dynamin and dynamin K44E (detected with HA.11 antibody) at the plasma membrane (arrowheads). Scale bar, 10 µm.


View larger version (56K):
[in this window]
[in a new window]
 
Fig. 2.   Characterization of cells expressing FLAGNK1R plus Rab5a or Rab5aS34N. KNRK cells were stably transfected with FLAGNK1R plus Rab5a-GFP or Rab5aS34N-GFP. A, analysis by flow cytometry confirmed coexpression of NK1R (detected with FLAG antibody) and Rab5a or Rab5aS34N (detected with EGFP). B, Western blotting using Rab5a or EGFP antibodies revealed high expression of Rab5a-GFP and Rab5aS34N-GFP chimeras of the predicted mass. C, confocal microscopy showed localization of NK1R (detected with FLAG antibody) at the cell surface (arrowheads), Rab5a-GFP in endosomes (arrows), and Rab5aS34N-GFP throughout the cytosol (arrows). Scale bar, 10 µm.

Dynamin and Rab5a Mediate Endocytosis of 125I-SP-- To quantitatively evaluate the importance of dynamin and Rab5a in NK1R endocytosis, we measured internalization of 125I-SP. Cells were incubated with 125I-SP for 60 min at 4 °C, washed, and incubated for 0-10 min at 37 °C, and surface and internalized label were separated by an acid wash. In KNRK-NK1R+DYN cells, 92 ± 8% of specifically bound SP was at the cell surface, and 8 ± 1% was internalized after 60 min at 4 °C (Fig. 3A). Warming to 37 °C resulted in rapid internalization of 125I-SP that was maximal within 10 min (28 ± 7% internalized at 2.5 min, 81 ± 7% at 5 min, and 90 ± 5% at 10 min) and was mirrored by a concomitant decline in surface 125I-SP. Similar results were obtained in cells expressing NK1R alone (4 ± 2% internalized at 0 min, 36 ± 5% 2.5 min, 77 ± 2% 5 min, 82 ± 1% 10 min). Expression of dynamin K44E did not affect SP binding at 4 °C but retarded endocytosis after warming (Fig. 3A). Inhibition was greatest at 5 min, when 82 ± 6% of specifically bound 125I-SP was internalized in KNRK-NK1R+DYN cells and only 45 ± 6% in KNRK-NK1R+DYNK44E cells (p < 0.05), representing an inhibition of endocytosis of 45%. In KNRK-NK1R+Rab5a cells, 95 ± 1% of specifically bound 125I-SP was at the surface, and 5 ± 1% was internalized after 60 min at 4 °C (Fig. 3B). Warming to 37 °C resulted in rapid internalization of 125I-SP that was maximal within 10 min (37 ± 3% internalized at 2.5 min, 81 ± 1% 5 min, 84 ± 1% 10 min). Expression of Rab5aS34N did not affect binding at 4 °C but reduced endocytosis after warming (Fig. 3B). Inhibition was greatest at 10 min, when 84 ± 1% of specifically bound 125I-SP was internalized in KNRK-NK1R+Rab5a cells and only 56 ± 4% in KNRK-NK1R+Rab5aS34N cells (p < 0.05, 32% inhibition). The inhibitory effects of dynamin K44E and Rab5aS34N diminished at 30 min (not shown). Thus, both dynamin and Rab5a mediate the early stages of SP-induced endocytosis of the NK1R.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 3.   Endocytosis of 125I-SP in KNRK-FLAGNK1R expressing HA-dynamin or HA-dynamin K44E in the pIRES-EGFP vector (A) and in KNRK-FLAGNK1R+Rab5a or KNRK-FLAGNK1R+Rab5aS34N cells (B). Expression of dominant negative dynamin K44E and Rab5aS34N strongly inhibited endocytosis. *, p < 0.05 compared with wild-type cells, n = 3 or 4 experiments in triplicate.

Dynamin Mediates Translocation of the Alexa-SP from the Cell Surface to Superficial Early Endosomes-- To identify the steps of endosome formation and trafficking that are mediated by dynamin, we localized the NK1R using Alexa594-SP with dynamin or dynamin K44E by immunofluorescence. Cells were incubated with Alexa594-SP for 60 min at 4 °C, washed, and incubated at 37 °C for 0-10 min. In cells expressing wild-type dynamin (KNRK-NK1R+DYN) after 60 min at 4 °C, dynamin was detected at the plasma membrane and in the cytosol, and Alexa594-SP and thus the NK1R were at the cell surface (Fig. 4, arrowheads). After 10 min at 37 °C, Alexa594-SP was detected in superficial and then perinuclear endosomes and dynamin remained at the plasma membrane (Fig. 4). In cells expressing dominant negative dynamin (KNRK-NK1R+DYNK44E) at 4 °C, dynamin K44E was detected in the cytosol at the plasma membrane, and Alexa594-SP was at the cell surface (Fig. 5). However, after 10 min at 37 °C, Alexa594-SP was retained at the cell surface in cells expressing dynamin K44E (Fig. 5, arrowheads). This result is in marked contrast to that observed in cells expressing wild-type dynamin (Fig. 4) or to untransfected cells (Fig. 5, asterisk). Retention at the cell surface was even observed after 30 min (not shown). Thus, dynamin mediates formation of early endosomes containing the NK1R.


View larger version (49K):
[in this window]
[in a new window]
 
Fig. 4.   Localization of Alexa594-SP and wild-type dynamin. KNRK-FLAGNK1R cells were transiently transfected with HA-dynamin. Cells were incubated with Alexa594-SP for 60 min at 4 °C, washed, and incubated at 37 °C for 0 or 10 min. Dynamin was localized by immunofluorescence using the HA.11 antibody. The same cells are shown in each row, and the images in the right panels are superimpositions of the images in the same row. After 0 min at 37 °C, Alexa594-SP was at the cell surface (arrowheads), and dynamin was in the cytoplasm and at the plasma membrane (arrowheads). After 10 min, Alexa594-SP was detected in perinuclear endosomes (arrows), and dynamin remained at the plasma membrane (arrowheads). Scale bar, 10 µm. Results shown are representative of three experiments.


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 5.   Localization of Alexa594-SP and dynamin K44E. KNRK-FLAGNK1R cells were transiently transfected with HA-dynamin K44E. Cells were incubated with Alexa594-SP for 60 min at 4 °C, washed, and incubated at 37 °C for 0 or 10 min. Dynamin K44E was localized by immunofluorescence using the HA.11 antibody. The same cells are shown in each row, and the images in the right panels are superimpositions of the images in the same row. After 0 min at 37 °C, Alexa594-SP was at the cell surface (arrowheads), and dynamin was in the cytoplasm and at the plasma membrane (arrowheads). After 10 min at 37 °C, in cells expressing dynamin K44E, Alexa594-SP was found at the cell surface (arrowheads). In contrast, Alexa-SP was detected in perinuclear endosomes in untransfected (asterisks, arrows). Dynamin K44E remained at the cell surface (arrowheads). Scale bar, 10 µm. Results shown are representative of three experiments.

Rab5a Mediates Translocation of the Alexa-SP from the Cell Surface to Superficial and Perinuclear Early Endosomes-- We similarly localized the NK1R and Rab5a. In cells expressing wild-type Rab5a (KNRK-NK1R-Rab5a) after 60 min at 4 °C, Rab5a-GFP was detected in multiple prominent vesicles and weakly at the plasma membrane, and Alexa594-SP was confined to the cell surface (Fig. 6). After 2.5 min at 37 °C, Alexa594-SP was localized to superficial vesicles, which also contained Rab5a-GFP (Fig. 6, arrows). After 5 and 10 min, Alexa594-SP was also detected in perinuclear vesicles containing Rab5a-GFP. We have previously reported that vesicles containing SP and the NK1R also contain the transferrin receptor and are thus early endosomes (11, 18). Similarly, Alexa594-SP underwent rapid endocytosis in cells not expressing Rab5a-GFP (Fig. 6, asterisk). In cells expressing dominant negative Rab5a (KNRK-NK1R-Rab5aS34N) at 4 °C, Rab5aS34N-GFP was in the cytosol and Alexa594-SP was confined to the cell surface (Fig. 7). After 2.5 min at 37 °C, Alexa594-SP was retained at the cell surface in KNRK-NK1R-Rab5aS34N cells (Fig. 7, arrowheads). In marked contrast, in KNRK-NK1R-Rab5a cells (Fig. 6) and in untransfected cells (Fig. 7, asterisk) Alexa594-SP was detected in superficial endosomes at 2.5 min. After 5 and 10 min in KNRK-NK1R-Rab5aS34N cells, Alexa594-SP was present at the cell surface (Fig. 7, arrowheads) and in superficial endosomes that did not proceed to a perinuclear location (Fig. 7, yellow arrows). In contrast, in KNRK-NK1R-Rab5a cells (Fig. 6) and untransfected cells (Fig. 7, asterisk) Alexa594-SP was found in perinuclear endosomes at 5 and 10 min. Thus, Rab5a mediates formation of early endosomes and their translocation to a perinuclear location.


View larger version (56K):
[in this window]
[in a new window]
 
Fig. 6.   Localization of Alexa594-SP and wild-type Rab5a-GFP. KNRK-FLAGNK1R cells were transiently transfected with Rab5a-GFP. Cells were incubated with Alexa594-SP for 60 min at 4 °C, washed, and incubated at 37 °C for 0-10 min. The same cells are shown in each row, and the images in the right panels are superimpositions of the images in the same row. After 0 min at 37 °C, Alexa594-SP was at the cell surface (arrowheads). After 2.5, 5, and 10 min, Alexa594-SP was detected in superficial and then perinuclear endosomes containing Rab5a-GFP (arrows). Alexa-594-SP was similarly internalized in untransfected cells (asterisks). Scale bar, 10 µm. Results shown are representative of three experiments.


View larger version (74K):
[in this window]
[in a new window]
 
Fig. 7.   Localization of Alexa594-SP and Rab5aS34N-GFP. KNRK-FLAGNK1R cells were transiently transfected with Rab5aS34N-GFP. Cells were incubated with Alexa594-SP for 60 min at 4 °C, washed, and incubated at 37 °C for 0-10 min. The same cells are shown in each row, and the images in the right panels are superimpositions of the images in the same row. After 0 min at 37 °C, Alexa594-SP was at the cell surface (arrowheads). In cells expressing Rab5aS34N-GFP, Alexa594-SP remained at the cell surface at 2.5 min (arrowheads). At 5 and 10 min, Alexa594-SP was found at the cell surface (arrowheads) and in superficial endosomes (yellow arrows) that did not proceed to a perinuclear location. In contrast, in untransfected cells, Alexa594-SP rapidly internalized into superficial and then perinuclear endosomes (asterisks, white arrows). Scale bar, 10 µm. Results shown are representative of three experiments.

Dynamin and Rab5a-mediated Endocytosis of the NK1R Are Not Required for Desensitization of SP-induced Ca2+ Mobilization-- Exposure of KNRK-NK1R cells co-expressing dynamin or dynamin K44E (Fig. 8A) and Rab5a or Rab5aS34N (Fig. 8B) to 10 nM SP for 2 min caused a prompt and transient increase in [Ca2+]i, confirming expression of functional receptors. When cells were washed and exposed again to 10 nM SP 5 min after the first challenge, the response was strongly desensitized in all cell lines (Fig. 8, A and B). We have previously reported a similar desensitization in cells expressing NK1R alone and shown that desensitization is not due to depletion of intracellular Ca2+ stores (27, 28). Desensitization occurred at a time when the NK1R was internalized in cells expressing wild-type dynamin and Rab5a but was at the cell surface in cells expressing dominant negative dynamin and Rab5a. Thus, dynamin- and Rab5a-mediated endocytosis are not required for desensitization of the NK1R.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 8.   Desensitization of SP-induced Ca2+ mobilization in KNRK-FLAGNK1R expressing HA-dynamin or HA-dynamin K44E in the pIRES-EGFP vector (A) and in KNRK-FLAGNK1R+Rab5a or KNRK-FLAGNK1R+Rab5aS34N cells (B). Cells were exposed to 10 nM SP or carrier (control) for 2 min, washed, and challenged with 10 nM SP 5 min later. In all cell lines, SP strongly desensitized the NK1R. Shown are representative traces of four observations.

Dynamin- and Rab5a-mediated Endocytosis of the NK1R Are Required for Resensitization of SP-induced Ca2+ Mobilization-- To examine resensitization, cells were incubated with 10 nM SP or vehicle for 10 min, washed, and challenged with 10 nM SP at 0-180 min after washing. In cells expressing FLAGNK1R alone, exposure to 10 nM SP for 10 min strongly desensitized SP-induced Ca2+ mobilization, which gradually resensitized when the interval between SP challenges increased beyond 10 min, such that complete resensitization occurred after 180 min (Fig. 9A). A similar degree of desensitization was observed in cells expressing wild-type or dominant negative dynamin or Rab5a (Fig. 9B). Resensitization was almost complete after 180 min in cells expressing wild-type dynamin (91 ± 23% resensitization) or Rab5a (79 ± 34% resensitization) (Fig. 9B). In marked contrast, after 180 min in cells expressing dynamin K44E or Rab5aS34N, responses to a second challenge with SP were resensitized by only 36 ± 12% and 12 ± 5%, respectively (p < 0.05) (Fig. 9B). Compared with cells expressing wild-type dynamin and Rab5a, dynamin K44E inhibited resensitization by 60%, and dominant negative Rab5aS34N inhibited resensitization by 85%. Thus, dynamin- and Rab5a-mediated trafficking of the NK1R are required for resensitization of responses to SP.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 9.   Resensitization of SP-induced Ca2+ mobilization in KNRK cells expressing FLAGNK1R alone and in KNRK-FLAGNK1R expressing HA-dynamin or HA-dynamin K44E in the pIRES-EGFP vector and in KNRK-FLAGNK1R+Rab5a or KNRK-FLAGNK1R+Rab5aS34N cells. Cells were exposed to 10 nM SP or vehicle (control) for 10 min, washed, and challenged with 10 nM SP 0-180 min later. A, the time course in cells expressing NK1R; B, response at 0 and 180 min in cells expressing wild-type and dominant negative dynamin and Rab5a. Note that expression of dynamin K44E and Rab5aS34N had no effect on desensitization at 0 min but strongly inhibit resensitization at 180 min. *, p < 0.05 compared with wild-type cells; n = 3 or 4 experiments in triplicate.

Dynamin but Not Rab5a-mediated Endocytosis Is Required for Mitogenic Signaling of the NK1R-- To determine the role of dynamin and Rab5a in SP activation of the MAP kinase cascade, we compared SP-induced ERK1/2 activation in cell lines expressing wild-type and dominant negative dynamin or Rab5a. Cells were incubated with SP for 0-30 min, and activation was determined by Western blotting using antibodies to pERK1/2 (activated) and total ERK1/2. Under basal conditions, there was a low level of phosphorylation of ERK1/2 in all cell lines. Densitometric analysis of the pERK1/2 and total ERK1/2 indicated that the basal level of activation was similar in all cells (pERK1/2 versus total ERK1/2 ratios: KNRK-NK1R+DYN, 0.6 ± 0.1; KNRK-NK1R+DYNK44EK, 0.5 ± 0.1; NRK-NK1R+Rab5a, 0.6 ± 0.1; KNRK-NK1R+Rab5aS34N, 0.5 ± 0.1). In cells expressing wild-type dynamin, SP stimulated a prompt increase in ERK1/2 phosphorylation that was maximal at 5 min (2.4-fold over basal) and remained elevated in the continued presence of SP after 30 min (Fig. 10A). We have previously reported similar results in KNRK cells expressing the NK1R alone and endothelial cells that naturally express the NK1R (16). Expression of EGFP alone did not alter this response (not shown). Expression of dynamin K44E strongly inhibited SP-induced phosphorylation of ERK1/2 (1.1-fold over basal at 5 min, p < 0.05). In cells expressing wild-type Rab5a, SP stimulated a rapid phosphorylation of ERK1/2 that was maximal after 2.5 min (2-fold over basal) and remained elevated for 30 min (Fig. 10B). Expression of Rab5aS34N had no effect on SP-induced phosphorylation of ERK1/2 (2-fold over basal at 2.5 min). Thus, dynamin- but not Rab5a-mediated trafficking of the NK1R is required for mitogenic signaling.


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 10.   SP-induced activation of ERK1/2. Cells expressing the NK1R with wild-type or dominant negative dynamin (A) or Rab5a (B) were incubated with 10 nM SP for the indicated times. Cells were analyzed by Western blotting using antibodies to pERK1/2 or total ERK1/2, for standardization. The upper panels show representative Western blots, and lower panels show the -fold increase over basal phosphorylation. *, p < 0.05 compared with wild-type cells, n = 4 experiments.

Alexa594-SP Colocalizes with Rab5a in Endosomes in Enteric Neurons Expressing the NK1R-- To confirm a potential role of dynamin and Rab5a in nontransfected cells, we studied myenteric neurons that naturally express the NK1R (30, 31, 46). We used rat neurons for studies of dynamin and guinea pig neurons for studies of Rab5a due to limitations in antibody specificity. Organotypic cultures of rat ileum were incubated with SP for 60 min at 4 °C, washed, and incubated for 0-20 min at 37 °C. The NK1R and dynamin were localized by immunofluorescence. At 4 °C, the NK1R was detected at the cell surface in the soma of a subpopulation of neurons (Fig. 11). Dynamin was detected in NK1R-positive neurons and in most other neurons, where it was predominantly cytosolic and also in close proximity to the plasma membrane. After 20 min at 37 °C, the NK1R was detected in endosomes, whereas the distribution of dynamin was unchanged. Cultures of guinea pig neurons were incubated with Alexa594-SP or Alexa594-[Sar9,MetO211]SP (similar results were obtained with both peptides) for 120 min at 4 °C, washed, and incubated for 0-30 at 37 °C. Rab5a was localized by immunofluorescence. After 0-2 min at 37 °C, Alexa594-SP and, thus, the NK1R were detected at the cell surface, and Rab5a was in endosomes (Fig. 12). After 5-10 min at 37 °C, Alexa594-SP was colocalized with Rab5a in endosomes in the soma and neurites. We have previously shown that these vesicles contain the transferrin receptor and are thus early endosomes (30). After 30 min, Alexa594-SP was present in perinuclear endosomes that did not contain Rab5a (not shown). Thus, myenteric neurons expressing the NK1R also express dynamin and Rab5a, and these proteins are appropriately localized within the cell to regulate trafficking of the NK1R.


View larger version (57K):
[in this window]
[in a new window]
 
Fig. 11.   Localization of NK1R and dynamin in rat myenteric neurons. Neurons were incubated with SP for 60 min at 4 °C, washed, and incubated at 37 °C for 0 or 20 min. NK1R and dynamin were detected by immunofluorescence. The same neurons are shown in each row, and the images in the right panels are superimpositions of the images in the same row. At 0 min, the NK1R was at the cell surface, and dynamin was in the cytosol close to the plasma membrane. After 20 min, NK1R was detected in endosomes (arrows), and the distribution of dynamin was unchanged. Scale bar, 10 µm.


View larger version (98K):
[in this window]
[in a new window]
 
Fig. 12.   Localization of Alexa594-SP or and Rab5a in guinea pig myenteric neurons. Neurons were incubated with Alexa594-SP for 120 min at 4 °C, washed, and incubated at 37 °C for 2 or 10 min. Rab5a was detected by immunofluorescence using a fluorescein isothiocyanate-conjugated secondary antibody. The same neurons are shown in each row, and the images in the right panels are superimpositions of the images in the same row. At 2 min, the NK1R was at the cell surface (arrowheads), and Alexa-SP was in endosomes. After 10 min, Alexa594-SP was in endosomes containing Rab5a (arrows). Scale bar, 5 µm.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

We found that expression of dominant mutants of dynamin 1 and Rab5a retarded SP-induced endocytosis of the NK1R. Dominant negative Rab5a also impeded the intracellular trafficking of endosomes containing the NK1R from a superficial to a perinuclear region. These mutants strongly inhibited resensitization of SP-induced Ca2+ mobilization but did not affect desensitization. Whereas dominant negative dynamin almost abolished SP-stimulated activation of ERK1/2, dominant negative Rab5a had no effect. Thus, our results indicate that dynamin and Rab5a are required for the formation of endosomes containing the NK1R and that Rab5a mediates their translocation to a perinuclear region. Dynamin and Rab5a-dependent trafficking of the NK1R is essential for resensitization of responses to SP, and dynamin-mediated endosome formation is required for coupling of the NK1R to the MAP kinase pathway. Moreover, dynamin and Rab5a are appropriately localized in neurons expressing the NK1R to suggest that they participate in the physiological regulation of NK1R trafficking and signaling. To our knowledge, this study is the first to demonstrate a role for dynamin and Rab5a in trafficking and signaling of the NK1R and the first report of the relative roles of dynamin and Rab5a in mitogenic signaling of a GPCR.

Molecular Mechanisms of SP-induced Endocytosis and Intracellular Trafficking of the NK1R-- Dynamin was detected at or near the plasma membrane under basal conditions, and dynamin K44E inhibited endocytosis of 125I-SP by ~50% at early time points (5 min) and caused retention of most Alexa-SP at the cell surface for prolonged periods (up to 30 min). The larger effect of dynamin K44E on endocytosis of Alexa-SP than on endocytosis of 125I-SP, suggests that dynamin K44E permits 125I-SP to be sequestered into a compartment at or near the plasma membrane, where it is resistant to removal by the acid wash that was used to separate cell surface from internalized peptide. However, the consensus of our results is that dynamin plays an important role in SP-induced endocytosis of the NK1R, and our findings support the hypothesis that dynamin mediates the final stages of endosome formation from clathrin-coated pits (32, 33). The observation that SP stimulates endocytosis of the NK1R by a clathrin-mediated mechanism in KNRK cells and enteric neurons supports a role for dynamin in endosome formation (18, 30). In support of our results, dynamin mediates endocytosis of receptors that constitutively internalize, such as the transferrin receptor (34), as well as GPCRs that internalize in response to agonist binding, including the beta 2-AR; delta -opioid; muscarinic m1, m3, and m4; and dopamine D1 receptors (12, 35, 37-39). However, dynamin is not required for endocytosis of angiotensin II type 1A, muscarinic m2, dopamine D2, and alpha 2B-adrenergic receptors (12, 37, 39, 40). The mechanisms of dynamin-independent endocytosis and the receptor domains that specify dynamin dependence remain to be determined.

Rab5a prominently colocalized with the internalized NK1R in superficial and perinuclear endosomes and is thus appropriately localized within cells to regulate NK1R trafficking. Rab5aS34N inhibited endocytosis of 125I-SP by ~35% and retarded endocytosis of Alexa-SP, supporting a role for Rab5a SP-induced endocytosis of the NK1R. In support of our results, Rab5a mediates the formation of endosomes containing the transferrin receptor (41-43), dopamine D2 receptor (38), and the beta 2-AR (44). Rab5aS34N also caused retention of the NK1R in superficial endosomes, indicating a requirement of Rab5a for translocation of endosomes from a superficial to a perinuclear region. Dominant negative Rab5a also impedes the kinetics of membrane trafficking in the endocytic pathway (41) and similarly causes retention of the beta 2-AR in endosomes close to the plasma membrane (44).

Although expression of dynamin K44E and Rab5aS34N markedly retarded SP endocytosis of the NK1R, they did not abolish this trafficking. Explanations include the possibility that the mutants were not expressed at high enough levels to completely inhibit the endogenous proteins or that additional mechanisms also contribute to trafficking. beta -Arrestins couple certain GPCRs to clathrin, including beta 2-AR, m2 muscarinic receptor, protease-activated receptor 2, and the NK1R (9-11, 23, 51). To interact with beta -arrestins, receptors must undergo phosphorylation, and G-protein receptor kinases 2 and 3 phosphorylate the NK1R in reconstituted systems and in cell lines (52-55). Dynamin acts downstream from beta -arrestins, by participating in endosome formation at clathrin-coated pits (32, 33). Rab5a is likely to participate in both the formation of these endosomes and their translocation to a perinuclear location (56, 57).

Role of SP-induced Endocytosis and Intracellular Trafficking of the NK1R for Signal Transduction-- Agonist-induced trafficking of GPCRs and associated proteins regulates cellular responses (1, 2). SP induces translocation of beta -arrestins to the plasma membrane, where they interact with the NK1R to mediate desensitization and endocytosis (11, 31). Endocytosis could contribute to desensitization by depleting the cell surface of receptors. However, dynamin K44E and Rab5aS34N, which inhibited NK1R endocytosis, did not affect desensitization of SP-induced Ca2+ mobilization, indicating that NK1R endocytosis is not the main mechanism of desensitization. In support of these findings, inhibition of NK1R endocytosis by dominant negative beta -arrestin-(319-418) or with drugs does not prevent desensitization (11, 20, 27). Thus, uncoupling of the NK1R from G-proteins is the main mechanism of desensitization. In a similar manner, uncoupling is the principal mechanism of desensitization of the beta 2-AR (1). However, down-regulation of the kappa -opioid receptor following prolonged activation requires endocytosis by dynamin, beta -arrestin and Rab5a-dependent mechanisms (24).

Dynamin K44E and Rab5aS34N markedly inhibited resensitization of SP-induced Ca2+ mobilization by ~60-85%. These results indicate that endocytosis and trafficking of the NK1R is necessary for recovery of responses to SP. In support of these findings, pharmacological inhibition of endocytosis and recycling and the NK1R and beta 2-AR disrupts their resensitization (19, 20), and Rab5aS34N also inhibits resensitization of beta 2-AR (44). Thus, resensitization of GPCRs requires endocytosis, dissociation from the receptor from ligand in acidified endosomes, receptor dephosphorylation and dissociation from beta -arrestins, and recycling.

Although agonist-stimulated endocytosis of some GPCRs is necessary for activation of the MAP kinase cascade, little is known about the relative contributions of beta -arrestin, dynamin and Rab5a to this process. We found that dynamin K44E, but not Rab5aS34N, abolished SP-induced activation of ERK1/2. We have previously reported that dominant negative beta -arrestin-(319-418) similarly inhibits this process (16). In support of our results, beta -arrestin- and dynamin-dependent endocytosis is also required for coupling the beta 2-AR, delta -opioid receptor, m1 muscarinic receptor, and proteinase-activated receptor-2 to the MAP kinase pathway (14, 15, 36, 58, 59). beta -Arrestins serve as scaffolds that recruit and organize components of the MAP kinase cascade including Src, in the case of the NK1R and beta 2-AR (14, 16), and Raf-1 in the case of the proteinase-activated receptor-2, where this interaction also determines the location and specificity of activated ERK1/2 (15). We found that inhibition of the proximal steps of endocytosis, by expression of dominant negative mutants of beta -arrestin and dynamin, inhibited SP-induced ERK1/2 activation, whereas disruption of Rab5a, which acts more distally, was without effect. Thus, for the same GPCR, inhibition of distinct steps of endocytosis and trafficking has different effects on coupling to the MAP kinase cascade. However, expression of dominant negative mutants of beta -arrestin and dynamin does not affect coupling of the CXCR2, kappa -opioid, or alpha 2-adrenergic receptors to ERK1/2 (60-62). Dynamin may have independent roles in GPCR internalization and MAP kinase activation, since dominant negative dynamin inhibits phorbol ester-stimulated MAP kinase activation, which is independent of receptor endocytosis and transactivation (63).

Physiological Relevance of NK1R Trafficking-- An understanding of the molecular mechanisms that regulate signaling by SP in the nervous system is of great interest, since the NK1R plays a major role in pain, depression, neurogenic inflammation, and gastrointestinal motility and secretion (25, 26). We found that myenteric neurons expressing the NK1R also express dynamin and Rab5a and that dynamin and Rab5a are appropriately located to regulate endocytosis and trafficking of the NK1R in the soma. SP induces membrane translocation of G-protein receptor kinases 2 and 3 and beta -arrestin 1/2 in these neurons, and disruption of the formation of clathrin-coated pits inhibits receptor endocytosis (30, 31). Thus, it is likely that clathrin, beta -arrestins, dynamin, and Rab5a mediate SP-induced endocytosis of the NK1R in neurons, as they do in transfected KNRK cells. Defects in these regulatory mechanisms may result in unregulated signaling and disease. Deletion of neutral endopeptidase EC 3.4.24.11, which degrades SP at the cell surface and thereby terminates signaling, results in exaggerated inflammatory effects of SP (64, 65). Alterations in the expression of other regulatory proteins, such as beta -arrestins, dynamin and Rab5a, may also result in uncontrolled signaling and disease.

    ACKNOWLEDGEMENTS

We thank Dr M. Zerial for the Rab5a and its mutant constructs, Dr. R. Vallee for dynamin and its mutant constructs, Paul Dazin for assistance with flow cytometry, J. H. Walsh (UCLA) for the EGFP antibody, and M. Lovett and Z. Vaughn for technical assistance.

    FOOTNOTES

* This work was supported by National Institutes of Health Grants DK39957 and DK43207 (to N. W. B.), DK 54155 and DK35740 (to C. S.), and DK52388 (to E. F. G.); Fondation pour la Recherché Medical; and Fondation Philippe (to F. S.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed: University of California San Francisco, 521 Parnassus Ave., San Francisco, CA 94143-0660. Tel.: 415-476-0489; Fax: 415-476-0936; E-mail: nigelb@itsa.ucsf.edu.

Published, JBC Papers in Press, April 16, 2001, DOI 10.1074/jbc.M101688200

    ABBREVIATIONS

The abbreviations used are: GPCR, G-protein-coupled receptor; SP, substance P; NK1R, neurokinin 1 receptor; beta 2-AR, beta 2-adrenergic receptor; ERK, extracellular signal-regulated kinase; pERK, phosphorylated ERK; MAP, mitogen-activated protein; GFP, green fluorescent protein; EGFP, enhanced GFP; PCR, polymerase chain reaction.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Böhm, S., Grady, E. F., and Bunnett, N. W. (1997) Biochem. J. 322, 1-18[Medline] [Order article via Infotrieve]
2. Luttrell, L. M., Daaka, Y., and Lefkowitz, R. J. (1999) Curr. Opin. Cell Biol. 11, 177-183[CrossRef][Medline] [Order article via Infotrieve]
3. Pitcher, J. A., Inglese, J., Higgins, J. B., Arriza, J. L., Casey, P. J., Kim, C., Benovic, J. L., Kwatra, M. M., Caron, M. G., and Lefkowitz, R. J. (1992) Science 257, 1264-1267[Medline] [Order article via Infotrieve]
4. Daaka, Y., Pitcher, J. A., Richardson, M., Stoffel, R. H., Robishaw, J. D., and Lefkowitz, R. J. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 2180-2185[Abstract/Free Full Text]
5. Barak, L. S., Warabi, K., Feng, X., Caron, M. G., and Kwatra, M. M. (1999) J. Biol. Chem. 274, 7565-7569[Abstract/Free Full Text]
6. Lohse, M. J., Benovic, J. L., Codina, J., Caron, M. G., and Lefkowitz, R. J. (1990) Science 248, 1547-1550[Medline] [Order article via Infotrieve]
7. Attramadal, H., Arriza, J. L., Aoki, C., Dawson, T. M., Codina, J., Kwatra, M. M., Snyder, S. H., Caron, M. G., and Lefkowitz, R. J. (1992) J. Biol. Chem. 267, 17882-17890[Abstract/Free Full Text]
8. Pippig, S., Andexinger, S., Daniel, K., Puzicha, M., Caron, M. G., Lefkowitz, R. J., and Lohse, M. J. (1993) J. Biol. Chem. 268, 3201-3208[Abstract/Free Full Text]
9. Goodman, O. B., Jr., Krupnick, J. G., Santini, F., Gurevich, V. V., Penn, R. B., Gagnon, A. W., Keen, J. H., and Benovic, J. L. (1996) Nature 383, 447-450[CrossRef][Medline] [Order article via Infotrieve]
10. Ferguson, S. S., Downey, W. E., Colapietro, A. M., Barak, L. S., Menard, L., and Caron, M. G. (1996) Science 271, 363-366[Abstract]
11. McConalogue, K., Dery, O., Lovett, M., Wong, H., Walsh, J. H., Grady, E. F., and Bunnett, N. W. (1999) J. Biol. Chem. 274, 16257-16268[Abstract/Free Full Text]
12. Zhang, J., Ferguson, S. S. G., Barak, L. S., Menard, L., and Caron, M. G. (1996) J. Biol. Chem. 271, 18302-18305[Abstract/Free Full Text]
13. Lee, K. B., Pals-Rylaarsdam, R., Benovic, J. L., and Hosey, M. M. (1998) J. Biol. Chem. 273, 12967-12972[Abstract/Free Full Text]
14. Luttrell, L. M., Ferguson, S. S., Daaka, Y., Miller, W. E., Maudsley, S., Della Rocca, G. J., Lin, F., Kawakatsu, H., Owada, K., Luttrell, D. K., Caron, M. G., and Lefkowitz, R. J. (1999) Science 283, 655-661[Abstract/Free Full Text]
15. DeFea, K. A., Zalevsky, J., Thoma, M. S., Dery, O., Mullins, R. D., and Bunnett, N. W. (2000) J. Cell Biol. 148, 1267-1281[Abstract/Free Full Text]
16. DeFea, K. A., Vaughn, Z. D., O'Bryan, E. M., Nishijima, D., Dery, O., and Bunnett, N. W. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 11086-11091[Abstract/Free Full Text]
17. von Zastrow, M., and Kobilka, B. K. (1992) J. Biol. Chem. 267, 3530-3538[Abstract/Free Full Text]
18. Grady, E. F., Garland, A. G., Gamp, P. D., Lovett, M., Payan, D. G., and Bunnett, N. W. (1995) Mol. Biol. Cell 6, 509-524[Abstract]
19. Yu, S. S., Lefkowitz, R. J., and Hausdorff, W. P. (1993) J. Biol. Chem. 268, 337-341[Abstract/Free Full Text]
20. Garland, A. M., Grady, E. F., Lovett, M., Vigna, S. R., Frucht, M. M., Krause, J. E., and Bunnett, N. W. (1996) Mol. Pharmacol. 49, 438-446[Abstract]
21. Brass, L. F., Pizarro, S., Ahuja, M., Belmonte, E., Blanchard, N., Stadel, J. M., and Hoxie, J. A. (1994) J. Biol. Chem. 269, 2943-2952[Abstract/Free Full Text]
22. Böhm, S. K., Khitin, L. M., Grady, E. F., Aponte, G., Payan, D. G., and Bunnett, N. W. (1996) J. Biol. Chem. 271, 22003-22016[Abstract/Free Full Text]
23. Dery, O., Thoma, M. S., Wong, H., Grady, E. F., and Bunnett, N. W. (1999) J. Biol. Chem. 274, 18524-18535[Abstract/Free Full Text]
24. Li, J. G., Benovic, J. L., and Liu-Chen, L. Y. (2000) Mol. Pharmacol. 58, 795-801[Abstract/Free Full Text]
25. Otsuka, M., and Yoshioka, K. (1993) Physiol. Rev. 73, 229-308[Free Full Text]
26. Kramer, M. S., Cutler, N., Feighner, J., Shrivastava, R., Carman, J., Sramek, J. J., Reines, S. A., Liu, G., Snavely, D., Wyatt-Knowles, E., Hale, J. J., Mills, S. G., MacCoss, M., Swain, C. J., Harrison, T., Hill, R. G., Hefti, F., Scolnick, E. M., Cascieri, M. A., Chicchi, G. G., Sadowski, S., Williams, A. R., Hewson, L., Smith, D., Carlson, E. J., et al.. (1998) Science 281, 1640-1645[Abstract/Free Full Text]
27. Garland, A. M., Grady, E. F., Payan, D. G., Vigna, S. R., and Bunnett, N. W. (1994) Biochem. J. 303, 177-186[Medline] [Order article via Infotrieve]
28. Bowden, J. J., Garland, A. M., Baluk, P., Lefevre, P., Grady, E. F., Vigna, S. R., Bunnett, N. W., and McDonald, D. M. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 8964-8968[Abstract]
29. Mantyh, P. W., DeMaster, E., Malhotra, A., Ghilardi, J. R., Rogers, S. D., Mantyh, C. R., Liu, H., Basbaum, A. I., Vigna, S. R., and Maggio, J. E. (1995) Science 268, 1629-1632[Medline] [Order article via Infotrieve]
30. Grady, E. F., Gamp, P. D., Baluk, P., McDonald, D. M., Payan, D. G., and Bunnett, N. W. (1996) Neuroscience 16, 1239-1254[CrossRef][Medline] [Order article via Infotrieve]
31. McConalogue, K., Corvera, C. U., Gamp, P. D., Grady, E. F., and Bunnett, N. W. (1998) Mol. Biol. Cell 9, 2305-2324[Abstract/Free Full Text]
32. McClure, S. J., and Robinson, P. J. (1996) Mol. Membr. Biol. 13, 189-215[Medline] [Order article via Infotrieve]
33. McNiven, M. A., Cao, H., Pitts, K. R., and Yoon, Y. (2000) Trends Biochem. Sci. 25, 115-120[CrossRef][Medline] [Order article via Infotrieve]
34. Herskovits, J. S., Burgess, C. C., Obar, R. A., and Vallee, R. B. (1993) J. Cell Biol. 122, 565-578[Abstract]
35. Chu, P., Murray, S., Lissin, D., and von Zastrow, M. (1997) J. Biol. Chem. 272, 27124-27130[Abstract/Free Full Text]
36. Vogler, O., Nolte, B., Voss, M., Schmidt, M., Jakobs, K. H., and van Koppen, C. J. (1999) J. Biol. Chem. 274, 12333-12338[Abstract/Free Full Text]
37. Vickery, R. G., and von Zastrow, M. (1999) J. Cell Biol. 144, 31-43[Abstract/Free Full Text]
38. Iwata, K., Ito, K., Fukuzaki, A., Inaki, K., and Haga, T. (1999) Eur. J. Biochem. 263, 596-602[Abstract/Free Full Text]
39. Vogler, O., Bogatkewitsch, G. S., Wriske, C., Krummenerl, P., Jakobs, K. H., and van Koppen, C. J. (1998) J. Biol. Chem. 273, 12155-12160[Abstract/Free Full Text]
40. Schramm, N. L., and Limbird, L. E. (1999) J. Biol. Chem. 274, 24935-24940[Abstract/Free Full Text]
41. Bucci, C., Parton, R. G., Mather, I. H., Stunnenberg, H., Simons, K., Hoflack, B., and Zerial, M. (1992) Cell 70, 715-728[Medline] [Order article via Infotrieve]
42. Roberts, R. L., Barbieri, M. A., Pryse, K. M., Chua, M., Morisaki, J. H., and Stahl, P. D. (1999) J. Cell Sci. 112, 3667-3675[Abstract/Free Full Text]
43. Trischler, M., Stoorvogel, W., and Ullrich, O. (1999) J. Cell Sci. 112, 4773-4783[Abstract/Free Full Text]
44. Seachrist, J. L., Anborgh, P. H., and Ferguson, S. S. (2000) J. Biol. Chem. 275, 27221-27228[Abstract/Free Full Text]
45. Bunnett, N. W., Dazin, P. F., Payan, D. G., and Grady, E. F. (1995) Peptides 16, 733-740[CrossRef][Medline] [Order article via Infotrieve]
46. Grady, E. F., Baluk, P., Böhm, S., Gamp, P., Wong, H., Payan, D. G., Ansel, J., Portbury, A. L., Furness, J. B., McDonald, D. M., and Bunnett, N. W. (1996) J. Neurosci. 16, 6975-6986[Abstract/Free Full Text]
47. McConalogue, K., Grady, E. F., Minnis, J., Balestra, B., Tonini, M., Brecha, N. C., Bunnett, N. W., and Sternini, C. (1999) Neuroscience 90, 1051-1059[CrossRef][Medline] [Order article via Infotrieve]
48. Sternini, C., Brecha, N. C., Minnis, J., D'Agostino, G., Balestra, B., Fiori, E., and Tonini, M. (2000) Neuroscience 98, 233-241[CrossRef][Medline] [Order article via Infotrieve]
49. Labrousse, A. M., Shurland, D. L., and van der Bliek, A. M. (1998) Mol. Biol. Cell 9, 3227-3239[Abstract/Free Full Text]
50. Vigna, S., Bowden, G., McDonald, D. M., Fisher, J., Okamoto, A., McVey, D. C., Payan, D., and Bunnett, N. W. (1994) J. Neurosci. 14, 834-845[Abstract]
51. Pals-Rylaarsdam, R., Gurevich, V. V., Lee, K. B., Ptasienski, J. A., Benovic, J. L., and Hosey, M. M. (1997) J. Biol. Chem. 272, 23682-23689[Abstract/Free Full Text]
52. Kwatra, M. M., Schwinn, D. A., Schreurs, J., Blank, J. L., Kim, C. M., Benovic, J. L., Krause, J. E., Caron, M. G., and Lefkowitz, R. J. (1993) J. Biol. Chem. 268, 9161-9164[Abstract/Free Full Text]
53. Nishimura, K., Warabi, K., Roush, E. D., Frederick, J., Schwinn, D. A., and Kwatra, M. M. (1998) Biochemistry 37, 1192-1198[CrossRef][Medline] [Order article via Infotrieve]
54. Roush, E. D., Warabi, K., and Kwatra, M. M. (1999) Mol. Pharmacol. 55, 855-862[Abstract/Free Full Text]
55. Vigna, S. R. (1999) J. Neurochem. 73, 1925-1932[Medline] [Order article via Infotrieve]
56. Olkkonen, V. M., and Stenmark, H. (1997) Int. Rev. Cytol. 176, 1-85[Medline] [Order article via Infotrieve]
57. Somsel Rodman, J., and Wandinger-Ness, A. (2000) J. Cell Sci. 113, 183-192[Abstract/Free Full Text]
58. Daaka, Y., Luttrell, L. M., Ahn, S., Della Rocca, G. J., Ferguson, S. S., Caron, M. G., and Lefkowitz, R. J. (1998) J. Biol. Chem. 273, 685-688[Abstract/Free Full Text]
59. Ignatova, E. G., Belcheva, M. M., Bohn, L. M., Neuman, M. C., and Coscia, C. J. (1999) J. Neurosci. 19, 56-63[Abstract/Free Full Text]
60. Yang, W., Wang, D., and Richmond, A. (1999) J. Biol. Chem. 274, 11328-11333[Abstract/Free Full Text]
61. Li, J. G., Luo, L. Y., Krupnick, J. G., Benovic, J. L., and Liu-Chen, L. Y. (1999) J. Biol. Chem. 274, 12087-12094[Abstract/Free Full Text]
62. DeGraff, J. L., Gagnon, A. W., Benovic, J. L., and Orsini, M. J. (1999) J. Biol. Chem. 274, 11253-11259[Abstract/Free Full Text]
63. Kranenburg, O., Verlaan, I., and Moolenaar, W. H. (1999) J. Biol. Chem. 274, 35301-35304[Abstract/Free Full Text]
64. Lu, B., Figini, M., Emanueli, C., Geppetti, P., Grady, E. F., Gerard, N. P., Ansel, J. C., Payan, D. G., Gerard, C., and Bunnett, N. W. (1997) Nat. Med. 3, 904-907[Medline] [Order article via Infotrieve]
65. Sturiale, S., Barbara, G., Qiu, B., Figini, M., Geppetti, P., Gerard, N., Gerard, C., Grady, E. F., Bunnett, N. W., and Collins, S. M. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 11653-11658[Abstract/Free Full Text]


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.